According to FutureWise analysis the market for assisted reproductive technology in 2023 is US$ 28.55 billion, and is expected to reach US$ 55.31 billion by 2031 at a CAGR of 8.60%.
Assisted Reproductive Technology (ART) is used to treat infertility. It encompasses fertility procedures that deal with both eggs and sperm. It operates by taking eggs out of the ovaries. Embryos are created by mixing the eggs and sperm. The embryos are subsequently returned to the parent's body. The most popular and efficient ART is in vitro fertilization (IVF). Donor eggs, donor sperm, or frozen embryos may be used during ART operations. A gestational carrier or surrogate may also be used. A surrogate is a woman who conceives the child using sperm from one. A gestational carrier conceives a child using an egg from one partner and sperm from the other. Multiple pregnancy is the most prevalent consequence of ART.
While the majority of individuals use ART to treat infertility, a few individuals also use it to prevent pregnancy problems or for genetic reasons. ART may also be called as fertility therapy or medically assisted reproduction by certain individuals. Due to the high cost and restricted coverage by private insurance, many people may find it challenging to get fertility procedures like ART. ART can help individuals and their families who are struggling with infertility, but it can also pose risks to the public's health, as shown by the high rates of multiple births, preterm births, and low birth weights associated with ART. It can be avoided or reduced by restricting the number of embryos implanted in the parent's body. Monitoring the effects of reproductive technologies, such as ART and contraception, has developed into a crucial public health endeavor.
FutureWise Market Research has published a report that provides an insightful analysis of assisted reproductive technology market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the assisted reproductive technology market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.